KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $39.4 billion.

  • AbbVie's Total Current Liabilities fell 852.49% to $39.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $39.4 billion, marking a year-over-year decrease of 852.49%. This contributed to the annual value of $38.7 billion for FY2024, which is 239.95% up from last year.
  • As of Q3 2025, AbbVie's Total Current Liabilities stood at $39.4 billion, which was down 852.49% from $39.8 billion recorded in Q2 2025.
  • AbbVie's 5-year Total Current Liabilities high stood at $43.1 billion for Q3 2024, and its period low was $27.6 billion during Q1 2023.
  • Its 5-year average for Total Current Liabilities is $35.1 billion, with a median of $34.8 billion in 2023.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 9398.34% in 2021, then tumbled by 1607.09% in 2022.
  • Quarter analysis of 5 years shows AbbVie's Total Current Liabilities stood at $35.2 billion in 2021, then fell by 16.07% to $29.5 billion in 2022, then increased by 28.11% to $37.8 billion in 2023, then rose by 2.4% to $38.7 billion in 2024, then increased by 1.66% to $39.4 billion in 2025.
  • Its Total Current Liabilities was $39.4 billion in Q3 2025, compared to $39.8 billion in Q2 2025 and $36.4 billion in Q1 2025.